UK markets close in 4 hours 37 minutes

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.3700-0.2400 (-5.21%)
At close: 04:00PM EDT
4.4000 +0.03 (+0.69%)
After hours: 07:26PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
21,281
35,642
-8,627
11,989
14,313
Depreciation & amortisation
7,461
12,024
3,760
3,538
3,492
Deferred income taxes
-5,828
-8,324
-3,618
-1,511
152
Stock-based compensation
17,014
16,451
19,555
24,756
21,998
Change in working capital
-40,693
-16,404
9,537
816
14,392
Accounts receivable
-51,139
-30,832
9,529
-3,113
18,481
Inventory
-27,599
-8,339
-13,833
-1,509
1,739
Accounts payable
-111
2,966
10,162
806
-4,455
Other working capital
21,008
50,523
27,896
48,750
55,209
Other non-cash items
2,379
1,449
2,128
4,609
1,639
Net cash provided by operating activities
21,225
50,701
28,219
49,497
55,986
Cash flows from investing activities
Investments in property, plant and equipment
-217
-178
-323
-747
-777
Acquisitions, net
1,264
-74,152
0
0
-
Purchases of investments
-12,500
-12,500
0
-17,500
0
Other investing activities
-
-
-5,000
-
-
Net cash used for investing activities
-86,870
-86,830
-5,323
-18,247
-777
Cash flows from financing activities
Debt repayment
-8,000
-67,236
-8,000
-115,000
-6,000
Common stock repurchased
-26,649
-18,004
-21,213
-34,999
-17,961
Other financing activities
-1,367
-2,716
-1,577
-1,525
-524
Net cash used provided by (used for) financing activities
-18,712
-6,209
-28,392
-37,870
-24,225
Net change in cash
-84,357
-42,338
-5,496
-6,620
30,984
Cash at beginning of period
99,741
97,659
103,155
109,775
78,791
Cash at end of period
15,384
55,321
97,659
103,155
109,775
Free cash flow
Operating cash flow
21,225
50,701
28,219
49,497
55,986
Capital expenditure
-217
-178
-323
-747
-777
Free cash flow
21,008
50,523
27,896
48,750
55,209